Fast Five Quiz: Non–Small Cell Lung Cancer (NSCLC) and RET Mutation

Maurie Markman, MD

August 22, 2022

Predictive biomarkers in the setting of non–small cell lung cancer (NSCLC) include gene fusions in tumors that have rearranged during transfection (RET). In NSCLC, chromosomal rearrangements between the RET gene and another domain lead to overexpression of the RET protein. These gene fusions have been identified as oncogenic drivers in multiple tumor types. They have the potential to cause chimeric, cytosolic proteins with constitutively active RET kinase domain, leading to increased cell proliferation, migration, and survival.

How familiar are you with RET rearrangements in NSCLC? Test your knowledge with this quick quiz.

1 2 3 4 5 6

Next Section

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Maurie Markman. Fast Five Quiz: Non–Small Cell Lung Cancer (NSCLC) and RET Mutation - Medscape - Aug 22, 2022.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....

Fast Five Quiz: Non–Small Cell Lung Cancer (NSCLC) and RET Mutation

Tables

Authors and Disclosures

Authors and Disclosures

Author(s)

Maurie Markman, MD

Comments

Email This

Feedback